News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innate Pharma Drops IPH 1101 Development



3/4/2011 8:15:03 AM

Scrip Intelligence -- The French firm Innate Pharma has stopped its development programme for IPH 1101, an agonist of gamma delta T cells, which had previously shown a possible clinical benefit in folicullar lymphoma and an anti-viral effect against type C viral hepatitis.

Read at News Release


comments powered by Disqus
   
Lymphoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES